July 7, 2015
Recommended Topic Related To:

Orbivan

"Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group. The me"...

Orbivan

ORBIVAN™
(butalbital, acetaminophen, and caffeine) Capsules, USP

DRUG DESCRIPTION

ORBIVAN™ Butalbital, Acetaminophen and Caffeine Capsules, USP are supplied in hard-gelatin capsule form for oral administration.

Each capsule contains the following active ingredients:

Butalbital, USP 50 mg
Acetaminophen, USP 300 mg
Caffeine, USP 40 mg

Inactive Ingredients: sodium lauryl sulfate, talc, microcrystalline cellulose, stearic acid, D&C yellow #10, FD&C red#40, titanium dioxide, FD&C blue #1, FD&C yellow #6, gelatin.

Butalbital (5-allyl-5-isobutylbarbituric acid), is a short to intermediate-acting barbiturate of molecular weight 212.25. It has the following structural formula:

Butalbital structural formula illustration

Acetaminophen (4'-hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic of molecular weight 151.16. It has the following structural formula:

Acetaminophen structural formula illustration

Caffeine (1,3,7-trimethylxanthine), is a central nervous system stimulant of molecular weight 194.19. It has the following structural formula:

Caffeine structural formula illustration

Last reviewed on RxList: 8/15/2011
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Living Better

Find the secrets to longer life.